3 unknown. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 3 |
| Phase 1 | 1 | Unknown 1 |
Follow Hemolysis: new trials by email Literature Review of Hemolysis trials Research Report on Hemolysis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hemolysis Related Complications in SCD. A Phase II Study With Voxelotor Voxelotor 1500 mg oral per day (GBT440) for 48 weeks in patients with sickle-cell disease - Sickle Cell Disease | Phase 2 | Unknown | Assistance Publique - Hôpitaux de Paris | 30 | 2023-03-22 | 2023-09-21 |
| A Study on the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of CAN106 in Subjects With PNH CAN106 20 mg/kg, CAN106 40 mg/kg, CAN106 80 mg/kg - PNH, Hemolysis | Phase 1 / Phase 2 | Unknown | CARE Pharma Shanghai Ltd. | 78 | 2022-03-25 | 2022-09-14 |
| Efficacy and Safety of Levamisole Combined With Standard Prednisolone in Warm Antibody Autoimmune Hemolytic Anemia. levamisole, Prednisone - Anemia, Anemia, Hemolytic | Phase 2 | Unknown | Institute of Hematology & Blood Diseases Hospital, China | 100 | 2012-04-01 | 2012-04-19 |
Anemia (1) · Anemia, Hemolytic (1) · Anemia, Hemolytic, Autoimmune (1) · Anemia, Sickle Cell (1) · Autoimmune Diseases (1) · Hematologic Diseases (1) · Immune System Diseases (1) · Pathologic Processes (1)
Pathological Conditions, Signs and Symptoms (3) · Hemic and Lymphatic Diseases (2) · Pathologic Processes (2) · Anemia (1) · Anemia, Hemolytic (1) · Anemia, Hemolytic, Congenital (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Hematologic Diseases (1) · Hemoglobinopathies (1)
Hemoglobin, Sickle (1) · Levamisole (1) · Prednisone (1) · WW Domain-Containing Oxidoreductase (1) · voxelotor (1)
Assistance Publique - Hôpitaux de Paris (1) · CARE Pharma Shanghai Ltd. (1) · Institute of Hematology & Blood Diseases Hospital, China (1)
China (2) · France (1)
Bing Han, MD (1) · Hongzhong Liu, MMed (1) · Pierre-Andre Natella, PHD (1) · Yizhou Zheng, doctor (1)